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Cochrane corner: does increasing intake of dietary fibre help in the 
prevention of cardiovascular disease in healthy individuals and those 
at high risk of developing the disease? 
Emma Loveman, Jill Colquitt, Karen Rees  
BACKGROUND 
Targeting modifiable cardiovascular risk factors is the key priority for public health in preventing the 
onset of cardiovascular disease (CVD). One area that has received a lot of attention is the intake of 
certain dietary components and dietary patterns which have been linked to the development of 
CVD,1 and a key focus of research has been identifying dietary components and patterns which may 
reduce the risk of CVD.  Some food manufacturers have exploited this message in their marketing 
strategies, for example claiming that their products are ‘heart healthy’.  But how much of this is 
based on high quality systematic reviews? Evidence for the potential benefits of various dietary 
components and patterns have been reviewed by the Cochrane Heart Group over recent years and 
the current review on dietary fibre adds to this evidence base.  We have conducted a Cochrane 
review of randomised controlled trials (RCTs) to investigate the potential effects of increasing dietary 
fibre to reduce cardiovascular disease events and risk factors.2  
There are thought to be several potential mechanisms by which fibre can lower CVD risk, including 
reducing the effect of postprandial blood glucose and lipid increases,3 increasing satiety and 
reducing low-density lipoprotein (LDL) cholesterol and total cholesterol through increased bile acid 
excretion. Two different types of fibre are proposed to benefit risk factors for CVD, soluble fibre (e.g. 
found in oat cereal, bran and pears) and insoluble fibre (e.g. found in whole grains, brown rice and 
cabbage).  It is not however clear whether soluble and insoluble fibre may be equally beneficial for 
cardiovascular health or whether one is superior. Despite observational studies suggesting that 
increased dietary fibre intake reduces the risk of mortality,4 general population studies show that 
levels of fibre consumption are well below recommendations.5 With fibre food products being of 
relatively low cost, it is possible the use of more fibre in diets to prevent CVD could be an 
inexpensive intervention to implement.  
REVIEW METHODS 
We examined evidence from RCTs of either dietary advice, the provision of high fibre foods or use of 
fibre supplements to prevent CVD.  We followed the methods of the Cochrane Handbook for 
Systematic Reviews (http://community.cochrane.org/handbook) following a protocol which defined 
the research question using inclusion criteria as outlined in Table 1.  Bibliographic databases 
(including the Cochrane library, MEDLINE, EMBASE and Web of Science) were searched from 
inception  until January 2015. 
Table 1: PICO summary for included RCTs assessing the effects of increased intake of dietary 
fibre to prevent CVD and key results. 
Population Adults at high risk of CVD (e.g.those who are  overweight, have 
metabolic syndrome, hypertension or raised cholesterol)  
Adults from the general population in primary prevention trials 
Intervention Dietary fibre interventions including advice to increase consumption or 
the provision of fibre supplements or high-fibre foods 
Comparator No intervention or minimal input interventions (e.g. the provision of a 
leaflet on dietary advice with no face to face reinforcement) 
Outcome Primary 
 All-cause mortality 
 Cardiovascular mortality 
 Non-fatal endpoints  (myocardial infarction, revascularisation, 
angiographically defined coronary heart disease, angina, stroke, 
carotid endarterectomy, peripheral artery disease) 
Secondary (surrogate markers of CVD risk) 
 Blood pressure  
 Blood lipids 
 Occurrence of type 2 diabetes  
 Health-related quality of life 
 Adverse effects 
 Costs 
Results 
Total cholesterol MD -0.20 mmol/L, (95% CI -0.34, -0.06), 20 comparisons, 1067 
participants, Heterogeneity 46% 
LDL cholesterol MD -0.14 mmol/L, (95% CI -0.22, -0.06), 18 comparisons, 995 
participants, Heterogeneity 36% 
HDL cholesterol MD -0.03 mmo//L, (95% CI -0.06, -0.01), 18 comparisons, 982 
participants, Heterogeneity 0% 
Triglycerides MD 0.00 mmol/L, (95% CI -0.04, 0.05), 18 comparisons, 982 
participants, Heterogeneity 32% 
Systolic blood pressure MD -1.92 mmHg, (95% CI -4.02,  0.19), 10 comparisons, 661 
participants, Heterogeneity 69% 
Diastolic blood pressure MD -1.77 mmHg, (95% CI -2.61, -0.92), 10 comparisons, 661 
participants, Heterogeneity 7% 
CI: confidence interval; CVD: Cardiovascular disease; HDL High density lipoprotein; LDL; MD: mean difference, PICO: 
population, intervention, comparator, outcomes; RCT: Randomised controlled trial 
 
REVIEW FINDINGS 
After sifting 4207 hits from searches and screening 253 full text papers, we found 23 RCTs that met 
our inclusion criteria.  Participants in the 23 RCTs were heterogeneous, with mean ages ranging 
between 35 to 58 years and the proportion of males ranging between 32% and 73%.  The majority of 
studies (n=16) were small with fewer than 40 participants. These studies were synthesized in meta-
analyses where possible.  Unfortunately, we did not identify any studies that assessed our primary 
outcomes of mortality or cardiovascular events.  However, studies were relatively short term 
(between 12 and 26 weeks duration) so there would not have been time for clinical events to accrue. 
Outcomes in the included trials were surrogate markers of CVD risk, including cholesterol and blood 
pressure. 
Nearly all of the studies had a risk of bias (Figure 1), for example, only three trials reported adequate 
randomisation and concealment of allocation.  A funnel plot indicated a likelihood of publication 
bias.  The effects of increasing fibre intake on our secondary outcomes are shown in Table 1.  A 
benefit of increasing dietary fibre was seen on total cholesterol and LDL cholesterol but not 
triglycerides or high density lipoprotein (HDL) cholesterol (the latter of which showed the opposite 
effect of that expected from increasing fibre).  Results of increasing fibre on blood pressure were 
significant only for diastolic blood pressure.  Few studies reported rates of adverse events and 
findings were inconsistent.  All studies reporting side-effects found rates overall to be low: four 
studies found similar rates of gastrointestinal events between groups and seven studies found 
gastrointestinal events to be more frequently reported in the fibre groups.  These events were 
typically flatulence but participants also reported constipation, nausea, bloating and diarrhoea. 
 
Subgroup analyses looking at the type of fibre did not find any significant effects on any of the lipid 
or blood pressure outcomes.  Although some trends were noted in the data for positive benefits for 
soluble fibre types (see for example Figure 1 for total cholesterol), there were generally few studies 
in the insoluble fibre group by which viable subgroup comparisons could be made. Therefore, we are 
unable to conclude whether soluble or insoluble fibre sources show different effects on these 
outcomes.   
 
Figure 1 - Effect of fibre type on total cholesterol 
 
LIMITATIONS OF THE EVIDENCE 
There were various limitations in the evidence we reviewed which prevent a clear view of the impact 
that increasing fibre may have on CVD. Firstly, no studies looked at our primary outcomes and only 
CVD risk factors could be assessed.  Secondly, nearly all of studies had various risks of bias which 
may have influenced results.  For example, looking at risk of selection bias, we found that just three 
RCTs reported an adequate method of randomisation and allocation concealment.  Other significant 
limitations of these RCTs included a short intervention period, mostly just 12 weeks, and small 
sample sizes, meaning many were likely underpowered.  Finally, there was a lack of consistency in 
the fibre interventions used in the studies.   
 
IMPLICATIONS 
Our review found no studies examining the effects of dietary fibre on our primary outcomes of 
cardiovascular clinical events and therefore our findings are based on factors considered to be 
markers of CVD risk, lipids and blood pressure.  Findings from this review of 23 RCTs are suggestive 
of a positive effect of dietary fibre on total cholesterol, LDL-cholesterol and diastolic blood pressure, 
but also a negative effect on HDL-cholesterol. Evidence is also uncertain as to whether there is a 
difference between soluble or insoluble fibre types, and as such we cannot make recommendations 
for changing practice on this basis.  
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